Country Profile: Spain
Children aged 2 to 11 months
At-risk groups aged 12-64, including chronic cardiovascular and respiratory disease; serious neurological and neuromuscular diseases; chronic liver disease; diabetes; coeliac disease; immunodeficiencies; immunosuppressive treatment; asplenia or severe non-functioning spleen; HIV infection; chronic renal failure and nephrotic syndrome; organ transplant patients; CSF leak or cochlear implant; previous episode of confirmed invasive pneumococcal disease; liver cirrhosis; Down’s Syndrome
All people over the age of 65
At-risk groups: 9.00%1 (2016)
Older adults: 11.00%2 (2017)
Vaccination advisory body/committee
National Vaccines Committee (Ponencia de Registro y Programa de Vacunaciones)
1 Figure taken from Ipsos Healthcare survey based on interviews with 1016 people aged 50 years and over.
2 Figure taken from Ipsos Healthcare survey based on interviews with 464 people aged 65 years and over.